Literature DB >> 1660231

Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma.

C M Smith1, P E Christie, R J Hawksworth, F Thien, T H Lee.   

Abstract

Urinary leukotriene E4 (LTE4) concentrations were measured in six asthmatic subjects after treadmill exercise, and in five asthmatic subjects after allergen challenge. Exercise and allergen challenge produced a 42 +/- 18% (mean +/- SD) and 22 +/- 8% fall in FEV1, respectively. The baseline concentration of urinary LTE4 in subjects challenged with exercise was 64 (27 to 150) pg/mg creatinine (geometric mean and 95% confidence interval), and in those challenged with allergen it was 36 (23 to 59) pg/mg creatinine. Urinary LTE4 concentrations did not change significantly in the 24 h after exercise. In contrast, there was a mean 4-fold increase in urinary LTE4 during the 3 h after allergen challenge.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660231     DOI: 10.1164/ajrccm/144.6.1411

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

Review 1.  The measurement of leukotrienes in human fluids.

Authors:  J Y Westcott
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Leukotriene activity modulation in asthma.

Authors:  S L Spector
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 3.  Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.

Authors:  I K Taylor
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

4.  Leukotrienes and aspirin induced asthma.

Authors:  T H Lee; P E Christie
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

Review 5.  LTC4 synthase. Enzymology, biochemistry, and molecular characterization.

Authors:  J F Penrose
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

6.  Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.

Authors:  T F Reiss; J B Hill; E Harman; J Zhang; W K Tanaka; E Bronsky; D Guerreiro; L Hendeles
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

7.  Inflammatory basis of exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Mark M Wurfel; Lawrence B Schwartz; William R Henderson; Moira L Aitken
Journal:  Am J Respir Crit Care Med       Date:  2005-06-09       Impact factor: 21.405

8.  Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.

Authors:  Tae-Rim Shin; Joo-Hee Kim; Cheol-Hong Kim; In-Gyu Hyun; Jeong-Hee Choi
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

9.  Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.

Authors:  S M Nasser; G S Bell; R J Hawksworth; K E Spruce; R MacMillan; A J Williams; T H Lee; J P Arm
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

10.  Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma.

Authors:  G Bochenek; E Nizankowska; A Gielicz; M Swierczyńska; A Szczeklik
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.